Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Aug. 31, 2020 |
Aug. 31, 2019 |
Aug. 31, 2020 |
Aug. 31, 2019 |
|
| Income Statement [Abstract] | ||||
| Revenue | $ 0 | $ 0 | $ 0 | $ 0 |
| Expenses | ||||
| Research and development, net (Note 13) | 2,749,222 | 970,213 | 4,229,810 | 1,968,074 |
| General and administrative (Note 13) | 2,049,241 | 1,718,613 | 4,002,323 | 3,621,243 |
| Depreciation and amortization (Notes 5 and 6) | 302,587 | 201,403 | 558,561 | 365,739 |
| Interest and other financial (Note 16) | (58,905) | 622,183 | 67,871 | 1,124,064 |
| Interest income | (18,039) | (192,259) | (58,386) | (192,291) |
| Foreign exchange loss | 103,618 | 21,890 | 180,259 | 9,764 |
| Total expenses | 5,127,724 | 3,342,043 | 8,980,438 | 6,896,593 |
| Net loss | (5,127,724) | (3,342,043) | (8,980,438) | (6,896,593) |
| Other comprehensive income (loss) | ||||
| Foreign currency translation adjustment | 402,812 | 102,457 | 232,400 | (37,685) |
| Comprehensive income (loss) | $ (4,724,912) | $ (3,239,586) | $ (8,748,038) | $ (6,934,278) |
| Loss per share | ||||
| Basic and diluted | $ (0.13) | $ (0.09) | $ (0.22) | $ (0.19) |
| Weighted average common shares outstanding | ||||
| Basic and diluted | 39,928,047 | 38,383,156 | 39,922,443 | 36,548,832 |